FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks - Xconomy https://t.co/NBTCr4AEYu
— IDRO (@IDROOhio) January 17, 2019
from Twitter https://twitter.com/IDROOhio
January 16, 2019 at 10:01PM
Thursday, January 17, 2019
FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks - Xconomy https://t.co/NBTCr4AEYu
from Twitter https://twitter.com/IDROOhio
January 16, 2019 at 10:01PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment